Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For:	[Subscribe] [Scholar Register]

Number	Cited by Other Article(s)
1	Okunowo AA, Ugwu AO, Kuku JO, Soibi-Harry AP, Okunowo BO, Ani-Ugwu NK, Osunwusi BO, Adenekan MA. Predictors, barriers and motivating factors for human papillomavirus vaccination and testing as preventive measures for cervical cancer: A study of urban women in Lagos, Nigeria. Prev Med Rep 2021;24:101643. [PMID: 34987955 PMCID: PMC8693866 DOI: 10.1016/j.pmedr.2021.101643] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2021] [Revised: 10/11/2021] [Accepted: 11/13/2021] [Indexed: 12/02/2022] Open Abstract • Uptake of HPV vaccination & testing was abysmally low despite good knowledge of it. • Unvaccinated and untested women were more willing to accept HPV test than vaccination. • Knowing CC patient, being employed & unmarried predicted HPV vaccination & testing. • Recommendation by HCP & friend/relative were motivators for HPV vaccination & test. • Fear, cost & non-recommendation by HCP were barriers to HPV vaccination & testing. Human papillomavirus (HPV) vaccination and HPV based cervical screening are scientifically proven ways to prevent and eliminate cervical cancer (CC). Unfortunately, these measures are yet to be widely accepted or utilized. Our study aimed to explore the individual-related factors that predict HPV vaccination and testing, its motivating factors and barriers among urban women in Lagos, Nigeria. This was a descriptive cross-sectional study among 208 consenting women who attended a community health awareness program in Surulere, Lagos, Nigeria, in September 2019. Structured questionnaires were interviewer administered and analysis was done using SPSS version 23. The uptake of HPV vaccination and testing was 29.0% and 3.0% respectively. Being employed [adjusted odds ratio (AOR) = 60.45, CI = 10.64–343.46, P < 0.001] and unmarried (AOR = 33.33, CI = 12.5–100.0, P < 0.001) predicted HPV vaccination uptake while being unmarried was the only predictor of uptake of HPV testing [crude odds ratio (COR) = 7.69, CI = 1.01–100.00, P = 0.039]. Knowing someone with CC (AOR = 21.64, CI = 4.87–96.16, P < 0.001) and being unmarried (AOR = 5.56, CI = 1.45–20.00, P = 0.012) predicted increased willingness to be vaccinated. Being unmarried (AOR = 5.26, CI = 1.89–14.29, P = 0.002) and knowing someone with CC (AOR = 6.41, CI = 2.68–15.33, P < 0.001) predicted willingness to do HPV testing. Recommendation by healthcare provider (HCP), friends/relatives and media were major motivators for HPV vaccination & testing while fear, cost, no recommendation by HCP, inaccessibility & lack of awareness were major barriers. There is need to urgently address these identified factors that affect HPV vaccination and testing in order to improve its acceptability and uptake rate in our environment. Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Okunowo AA, Ugwu AO, Kuku JO, Soibi-Harry AP, Okunowo BO, Ani-Ugwu NK, Osunwusi BO, Adenekan MA. Predictors, barriers and motivating factors for human papillomavirus vaccination and testing as preventive measures for cervical cancer: A study of urban women in Lagos, Nigeria. Prev Med Rep 2021;24:101643. [PMID: 34987955 PMCID: PMC8693866 DOI: 10.1016/j.pmedr.2021.101643] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2021] [Revised: 10/11/2021] [Accepted: 11/13/2021] [Indexed: 12/02/2022] Open

Abstract

•

Uptake of HPV vaccination & testing was abysmally low despite good knowledge of it.

•

Unvaccinated and untested women were more willing to accept HPV test than vaccination.

•

Knowing CC patient, being employed & unmarried predicted HPV vaccination & testing.

•

Recommendation by HCP & friend/relative were motivators for HPV vaccination & test.

•

Fear, cost & non-recommendation by HCP were barriers to HPV vaccination & testing.

Human papillomavirus (HPV) vaccination and HPV based cervical screening are scientifically proven ways to prevent and eliminate cervical cancer (CC). Unfortunately, these measures are yet to be widely accepted or utilized. Our study aimed to explore the individual-related factors that predict HPV vaccination and testing, its motivating factors and barriers among urban women in Lagos, Nigeria. This was a descriptive cross-sectional study among 208 consenting women who attended a community health awareness program in Surulere, Lagos, Nigeria, in September 2019. Structured questionnaires were interviewer administered and analysis was done using SPSS version 23. The uptake of HPV vaccination and testing was 29.0% and 3.0% respectively. Being employed [adjusted odds ratio (AOR) = 60.45, CI = 10.64–343.46, P < 0.001] and unmarried (AOR = 33.33, CI = 12.5–100.0, P < 0.001) predicted HPV vaccination uptake while being unmarried was the only predictor of uptake of HPV testing [crude odds ratio (COR) = 7.69, CI = 1.01–100.00, P = 0.039]. Knowing someone with CC (AOR = 21.64, CI = 4.87–96.16, P < 0.001) and being unmarried (AOR = 5.56, CI = 1.45–20.00, P = 0.012) predicted increased willingness to be vaccinated. Being unmarried (AOR = 5.26, CI = 1.89–14.29, P = 0.002) and knowing someone with CC (AOR = 6.41, CI = 2.68–15.33, P < 0.001) predicted willingness to do HPV testing. Recommendation by healthcare provider (HCP), friends/relatives and media were major motivators for HPV vaccination & testing while fear, cost, no recommendation by HCP, inaccessibility & lack of awareness were major barriers. There is need to urgently address these identified factors that affect HPV vaccination and testing in order to improve its acceptability and uptake rate in our environment.

Collapse